PUMA BIOTECHNOLOGY
Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.
PUMA BIOTECHNOLOGY
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.pumabiotechnology.com
Total Employee:
251+
Status:
Active
Contact:
310-443-4150
Email Addresses:
[email protected]
Total Funding:
809.3 M USD
Technology used in webpage:
SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Equity - Puma Biotechnology
Alan H. Auerbach
Alan H. Auerbach investment in Post-IPO Equity - Puma Biotechnology
Armentum Partners
Armentum Partners investment in Post-IPO Debt - Puma Biotechnology
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Puma Biotechnology
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Equity - Puma Biotechnology
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Equity - Puma Biotechnology
OrbiMed
OrbiMed investment in Post-IPO Equity - Puma Biotechnology
Sahsen Ventures
Sahsen Ventures investment in Post-IPO Equity - Puma Biotechnology
H&Q Healthcare Investors
H&Q Healthcare Investors investment in Post-IPO Equity - Puma Biotechnology
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Puma Biotechnology
Official Site Inspections
http://www.pumabiotechnology.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.78 K
- Host name: 33.187.62.50.host.secureserver.net
- IP address: 50.62.187.33
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260